Novel Complex of PD-L1 Aptamer and Albumin Enhances Antitumor Efficacy In Vivo
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27051482
Abstract: The PD-1/PD-L1 pathway blockade can generate a good clinical response by reducing immunosuppression and provoking durable antitumor immunity. In addition to antibodies, aptamers can also block the interaction between PD-1 and PD-L1. For the in… read more here.
Keywords: bsa apt; antitumor efficacy; aptamer albumin; aptamer ... See more keywords